Xencor to Present at Upcoming Investor Conferences
11 November 2022 - 08:01AM
Business Wire
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical
company developing engineered antibodies and cytokines for the
treatment of cancer and autoimmune diseases, today announced that
company management will participate at two upcoming investor
conferences:
- Jefferies London Healthcare Conference Date: Tuesday,
November 15, 2022 Presentation Time: 8:00 a.m. GMT / 12:00 a.m. PST
Location: London
- Piper Sandler 34th Annual Healthcare Conference Date:
Tuesday, November 29, 2022 Presentation Time: 12:30 p.m. EST / 9:30
a.m. PST Location: New York
Live webcasts of these presentations will be available under
"Events & Presentations" in the Investors section of the
Company's website located at www.xencor.com. Replays of the events
will be available on the Xencor website for at least 30 days
following the presentations.
About Xencor
Xencor is a clinical-stage biopharmaceutical company developing
engineered antibodies and cytokines for the treatment of patients
with cancer and autoimmune diseases. More than 20 candidates
engineered with Xencor's XmAb® technology are in clinical
development, and three XmAb medicines are marketed by partners.
Xencor's XmAb engineering technology enables small changes to a
protein's structure that result in new mechanisms of therapeutic
action. For more information, please visit www.xencor.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221110005834/en/
Charles Liles cliles@xencor.com 626-737-8118
Xencor (NASDAQ:XNCR)
Historical Stock Chart
From Mar 2024 to Mar 2024
Xencor (NASDAQ:XNCR)
Historical Stock Chart
From Mar 2023 to Mar 2024